acceso
Oriol Mirallas, MD, BSc, MS
Early Drug Development Unit (UITM), Vall d´Hebron University Hospital, Barcelona
Alejandro García-Álvarez, MD
Medical Oncology Department. Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO)
Javier Arroyo-Rodenas, PharmD, MSc
Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre
Una iniciativa científica de:
Con el patrocinio de: